ÌÇÐÄvlog

[Skip to Navigation]
Sign In

October 2024 - April 2016

Decade

Year

Issue

February 2022, Vol 7, No. 2, Pages 121-236

Original Investigation

Evaluation of Quality of Care for US Veterans With Recent-Onset Heart Failure With Reduced Ejection Fraction

Abstract Full Text
free access
JAMA Cardiol. 2022;7(2):130-139. doi:10.1001/jamacardio.2021.4585

This cohort study evaluates the use of guideline-directed medical therapy and implantable cardioverter-defibrillator as well as mortality rates over a 6-year period among patients with heart failure with reduced ejection fraction in the US Department of Veterans Affairs health care system.

Economic Outcomes of Rehabilitation Therapy in Older Patients With Acute Heart Failure in the REHAB-HF Trial: A Secondary Analysis of a Randomized Clinical Trial

Abstract Full Text
free access
JAMA Cardiol. 2022;7(2):140-148. doi:10.1001/jamacardio.2021.4836

This secondary analysis of a randomized clinical trial’s economic outcomes reports the cumulative medical resource use and costs during the 6-month follow-up period for patients randomized to an intervention or control condition for acute decompensated heart failure.

Racial, Ethnic, and Socioeconomic Disparities in Access to Transcatheter Aortic Valve Replacement Within Major Metropolitan Areas

Abstract Full Text
free access
JAMA Cardiol. 2022;7(2):150-157. doi:10.1001/jamacardio.2021.4641

This national cross-sectional analysis examines the association between zip code–level racial, ethnic, and socioeconomic composition and rates of transcatheter aortic valve replacement among Medicare patients living within large metropolitan areas in the US.

Prevalence and Disease Spectrum of Extracoronary Arterial Abnormalities in Spontaneous Coronary Artery Dissection

Abstract Full Text
open access
JAMA Cardiol. 2022;7(2):159-166. doi:10.1001/jamacardio.2021.4690

This case series examines the prevalence of fibromuscular dysplasia and other extracoronary events in patients who develop spontaneous coronary artery dissection.

Individualized Studies of Triggers of Paroxysmal Atrial Fibrillation: The I-STOP-AFib Randomized Clinical Trial

Abstract Full Text
free access has audio
JAMA Cardiol. 2022;7(2):167-174. doi:10.1001/jamacardio.2021.5010

This randomized clinical trial tests the hypothesis that n-of-1 trials of self-selected atrial fibrillation triggers would enhance atrial fibrillation–related quality of life.

Outcomes Associated With Catheter Ablation of Ventricular Tachycardia in Patients With Cardiac Sarcoidosis

Abstract Full Text
free access
JAMA Cardiol. 2022;7(2):175-183. doi:10.1001/jamacardio.2021.4738

This cohort study investigates outcomes associated with ventricular tachycardia ablation in patients with cardiac sarcoidosis.

Metabolomic Analysis of Coronary Heart Disease in an African American Cohort From the Jackson Heart Study

Abstract Full Text
free access
JAMA Cardiol. 2022;7(2):184-194. doi:10.1001/jamacardio.2021.4925

This cohort study examines metabolites associated with incident coronary heart disease and coronary artery calcium among African American participants in the Jackson Heart Study and seeks to replicate coronary heart disease findings among multiethnic participants in the Women’s Health Initiative.

Inclusion of Smoking Data in Cardiovascular Disease Risk Estimation

Abstract Full Text
free access
JAMA Cardiol. 2022;7(2):195-203. doi:10.1001/jamacardio.2021.4990

This cohort study evaluates the predictive utility of adding former smoking status, pack-years smoked, and years since quitting to the American College of Cardiology/American Heart Association 2013 pooled cohort equations for more accurate atherosclerotic cardiovascular disease risk prediction.

Association of Differences in Treatment Intensification, Missed Visits, and Scheduled Follow-up Interval With Racial or Ethnic Disparities in Blood Pressure Control

Abstract Full Text
free access has audio
JAMA Cardiol. 2022;7(2):204-212. doi:10.1001/jamacardio.2021.4996

This cohort study assesses whether and to what extent differences in treatment intensification, scheduled follow-up interval, and missed visits are associated with racial and ethnic disparities in blood pressure control among adults with hypertension.

Brief Report

Optimizing Training Response for Women in Cardiac Rehabilitation: A Randomized Clinical Trial

Abstract Full Text
free access
JAMA Cardiol. 2022;7(2):215-218. doi:10.1001/jamacardio.2021.4822

This randomized clinical trial evaluates the effect of high-intensity interval training and intensive lower extremity resistance training compared with standard moderate intensity continuous training on peak oxygen uptake among women in cardiac rehabilitation.

Research Letter

Management of Severe and Moderate Hypercholesterolemia in Young Women and Men

Abstract Full Text
free access has audio
JAMA Cardiol. 2022;7(2):227-230. doi:10.1001/jamacardio.2021.4983

This study uses clinical registry data to assess achievement of low-density lipoprotein cholesterol reduction and lipid-lowering therapy prescribing patterns among adults aged 20 to 39 years with moderate to severe hypercholesterolemia.

Viewpoint

Addressing Imaging Pitfalls to Reduce Cardiovascular Disease Misdiagnosis in Patients With Breast Cancer Following Reconstruction

Abstract Full Text
JAMA Cardiol. 2022;7(2):123-125. doi:10.1001/jamacardio.2021.4564

This Viewpoint discusses the challenges of cardiovascular imaging in patients with breast cancer after reconstruction.

The Gig Economy Worker—A New Social Determinant of Health?

Abstract Full Text
JAMA Cardiol. 2022;7(2):125-126. doi:10.1001/jamacardio.2021.5435

This Viewpoint discusses how the rapid rise of the gig economy has resulted in a fast-growing workforce segment with unique health vulnerabilities.

From the Heart

The Inglorious Art

Abstract Full Text
free access
JAMA Cardiol. 2022;7(2):127. doi:10.1001/jamacardio.2021.5701

This essay discusses how the wounding and treatment of Aeneas in the Aeneid can be interpreted as a metaphor for basic science advancing medical practice.

Editorial

Treating Severe Hypercholesterolemia—If Not Now, When?

Abstract Full Text
has audio
JAMA Cardiol. 2022;7(2):128-129. doi:10.1001/jamacardio.2021.4987
Invited Commentary

Health Status and Cardiac Rehabilitation—Putting a Dollar Amount on Improvement

Abstract Full Text
JAMA Cardiol. 2022;7(2):148-149. doi:10.1001/jamacardio.2021.4844

Treatment Intensification and Missed Visits as Important Targets for Reducing Racial and Ethnic Disparities in Hypertension Control

Abstract Full Text
has audio
JAMA Cardiol. 2022;7(2):213-214. doi:10.1001/jamacardio.2021.5003
Review

Role of Coronary Artery Calcium Testing for Risk Assessment in Primary Prevention of Atherosclerotic Cardiovascular Disease: A Review

Abstract Full Text
JAMA Cardiol. 2022;7(2):219-224. doi:10.1001/jamacardio.2021.3948

This narrative review provides an overview of coronary artery calcium testing as a tool for risk assessment in the prevention of atherosclerotic cardiovascular disease.

JAMA Cardiology Clinical Challenge

A Man With Left Ventricular Hypertrophy

Abstract Full Text
has multimedia
JAMA Cardiol. 2022;7(2):225-226. doi:10.1001/jamacardio.2021.5144

A man in his 40s with a 20-year history of bilateral sensorineural hearing loss was referred for evaluation of left ventricular hypertrophy detected by echocardiography. On physical examination, he was 154 cm tall and weighed 38 kg and neurological examination showed mild cognitive impairment, poor coordination, and muscle weakness of the bilateral lower limbs. What would you do next?

Cardiovascular Images

A 49-Year-Old Woman With Progressive Dyspnea

Abstract Full Text
online only
JAMA Cardiol. 2022;7(2):e214920. doi:10.1001/jamacardio.2021.4920

This case report describes a woman with heart failure and low-voltage electrocardiogram who had periorbital ecchymosis and apical sparing.

JAMA Cardiology Patient Page

Hereditary Transthyretin Amyloid Cardiomyopathy

Abstract Full Text
free access
JAMA Cardiol. 2022;7(2):236. doi:10.1001/jamacardio.2021.5006

This Patient Page describes the causes, symptoms, diagnosis, genetic testing, and treatment of amyloidogenic transthyretin.

Comment & Response

Role of Income-Lifting Social Programs in Reducing Years of Life Lost to Myocardial Infarction and Sudden Death

Abstract Full Text
JAMA Cardiol. 2022;7(2):230. doi:10.1001/jamacardio.2021.5127

Role of Income-Lifting Social Programs in Reducing Years of Life Lost to Myocardial Infarction and Sudden Death—Reply

Abstract Full Text
JAMA Cardiol. 2022;7(2):230-231. doi:10.1001/jamacardio.2021.5130

Lifestyle Modification Is Appropriate as Primary Prevention

Abstract Full Text
JAMA Cardiol. 2022;7(2):231-232. doi:10.1001/jamacardio.2021.5238

Lifestyle Modification Is Appropriate as Primary Prevention—Reply

Abstract Full Text
JAMA Cardiol. 2022;7(2):232. doi:10.1001/jamacardio.2021.5241
Editor's Note

Race Bias in Transcatheter Aortic Valve Replacement: Are We Sure?

Abstract Full Text
JAMA Cardiol. 2022;7(2):158. doi:10.1001/jamacardio.2021.4647
Correction

Error in the First Paragraph

Abstract Full Text
free access
JAMA Cardiol. 2022;7(2):233. doi:10.1001/jamacardio.2021.5225
JAMA Cardiology Masthead

JAMA Cardiology

Abstract Full Text
free access
JAMA Cardiol. 2022;7(2):121. doi:10.1001/jamacardio.2021.4271
×